Ajinomoto BioPharma Services

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization headquartered in San Diego, California. The company employs 482 people and generates over $1 billion in annual revenue. Ajinomoto Bio-Pharma Services operates globally with additional sites in Belgium, Japan, and India. This organization provides comprehensive development, cGMP manufacturing, and aseptic fill finish services for a variety of pharmaceutical products. Their offerings encompass both small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services boasts a diverse portfolio of innovative platforms and capabilities, catering to projects ranging from pre-clinical and pilot programs to full-scale commercial production. These include Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, and continuous flow manufacturing. Ajinomoto Bio-Pharma Services is committed to delivering a high standard of quality and service to meet the unique needs of its clients. Their extensive experience and cutting-edge technologies allow them to support clients throughout the entire drug development lifecycle. For more information, please visit www.AjiBio-Pharma.com.